Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Answering Your Questions About Bipolar Depression

Following 2 recent Psychiatry Update meetings, Dr Charles DeBattista answers your most asked questions on bipolar depression with mixed features.
Charles DeBattista, MD
Amber Hoberg, PMHNP
Greg W. Mattingly, MD
Released: August 1, 2022

Get answers to the questions that you and your colleagues have asked! In this episode, Charles DeBattista, MD, provides answers to audience questions that were submitted at 2 recent Psychiatry Update meetings. His thoughtful responses cover your questions on differential diagnosis, initiating pharmacotherapy, medication management, and more. Moderators Amber Hoberg, PMHNP, and Greg W. Mattingly, MD, provide complementary commentary throughout the Q&A session, adding interprofessional perspective to the activity.

Information on this Educational Activity

Faculty

Charles DeBattista, MD

Chief, Depression Research Clinic
Director, Medical Student Education in Psychiatry
Professor of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Charles DeBattista, DMH, MD: researcher: Biolite, Compass, Janssen, Myriad, Neurocentria, Relmada, Sage; consultant: AbbVie, Corcept.
Amber Hoberg, PMHNP

Nurse Practitioner
MorningStar Family Medicine
Floresville, Texas

Amber Hoberg, PMHNP: consultant: Acadia, Avanir, BioXcel, Intracellular Therapies, Neurocrine, Teva.
Greg W. Mattingly, MD

Associate Clinical Professor
Psychiatry
Washington University School of Medicine
St Louis, Missouri
President
Midwest Research Group
St. Louis, Missouri

Greg W. Mattingly, MD: speaker: AbbVie, Alkermes, Corium, Eisai, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris Pharma; consultant: AbbVie, Acadia, Alkermes, Axsome, Corium, Eisai, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neos, Neurocrine, Noven, Otsuka, Redax, Rhodes, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, Teva, Tris Pharma; researcher: AbbVie, Acadia, Akili, Alkermes, Axsome, Boehringer, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, NLS-1 Pharma AG, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Intra-Cellular Therapies, Inc.

Related Content

Slides from a presentation that educates clinicians on new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.

Marwan Sabbagh, MD, FAAN Released: September 19, 2022

Access this medications glossary for a list of common psychiatric medications.

Released: September 6, 2022

Experts in psychiatry discuss the patient symptoms and clues that can help to accurately diagnose bipolar depression, from Clinical Care Options (CCO)

Vladimir Maletic, MD Greg W. Mattingly, MD Released: September 2, 2022

Slides from a presentation that educates clinicians on managing major depression.

Manish Jha, MD Vladimir Maletic, MD Greg W. Mattingly, MD Released: August 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings